[1]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165-166.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Medical Information,2019,32(05):165-166.[doi:10.3969/j.issn.1006-1959.2019.05.054]
点击复制

血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年05期
页码:
165-166
栏目:
中医中药
出版日期:
2019-03-01

文章信息/Info

Title:
Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium
文章编号:
1006-1959（2019）05-0165-02
作者:
徐润鸿
（江西省上饶市第二人民医院内科，江西 上饶 334000）
Author(s):
XU Run-hong
(Department of Internal Medicine,the Second People’s Hospital of Shangrao City,Shangrao 334000,Jiangxi,China)
关键词:
急性脑梗死; 血府逐瘀汤; 阿托伐他汀
Keywords:
Acute cerebral infarction; Xuefu Zhuyu Decoction; Atorvastatin
分类号:
R543.4
DOI:
10.3969/j.issn.1006-1959.2019.05.054
文献标志码:
A
摘要:
目的 观察血府逐瘀汤联合他汀类治疗急性脑梗死的临床疗效。方法 选取2017年10月~2018年10月江西省上饶市第二人民医院门诊或住院所接收的120例急性脑梗死患者，随机分为对照组及治疗组，每组60例。对照组采用常规西医治疗，治疗组在对照组基础上加用血府逐瘀汤及阿托伐他汀钙治疗，疗程2周。比较两组临床疗效及不良反应发生情况。结果 治疗组总有效率为93.33%，高于对照组的76.67%，差异有统计学意义（P＜0.05），两组治疗期间均无明显不良反应发生。结论 在西医基础上采用血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死患者，可明显改善患者的临床症状，有较好疗效，且未增加明显的不良反应。
Abstract:
Objective To observe the clinical efficacy of Xuefu Zhuyu Decoction combined with statins in the treatment of acute cerebral infarction. Methods A total of 120 patients with acute cerebral infarction received from the outpatient or inpatient department of the Second People’s Hospital of Shangrao City, Jiangxi Province from October 2017 to October 2018 were randomly divided into the control group and the treatment group, with 60 cases in each group. The control group was treated with conventional western medicine. The treatment group was treated with Xuefu Zhuyu Decoction and atorvastatin calcium on the basis of the control group for 2 weeks. The clinical effects and adverse reactions were compared between the two groups.Results The total effective rate of the treatment group was 93.33%, which was higher than that of the control group 76.67%,the difference was statistically significant (P<0.05). There was no obvious adverse reaction during the treatment period. Conclusion On the basis of Western medicine, Xuefu Zhuyu Decoction combined with atorvastatin calcium in the treatment of patients with acute cerebral infarction can significantly improve the clinical symptoms of patients, has a good effect, and does not increase the obvious adverse reactions.

参考文献/References:


[1]周永安,刘路芬,芮成俊.中西医结合治疗急性脑梗死36例[J].光明中医,2008,23(6)：755-756.
[2]杨小清.补阳还五汤治疗中风病气虚血瘀证的机制探讨[J]现代中西医结合杂志,2005,14(2):190-191.
[3]董晓会.中医护理联合常规护理对脑梗死患者临床疗效的影响[J].中国民间疗法,2018,26(1):80-81.
[4]王晓萍,周明旺,刘雪君,等.中西医结合治疗帕金森病临床研究新进展[J].辽宁中医药大学学报,2017(11):217-220.
[5]郝玉蕾,辛美萤,朱颖.MicroRNAs在动脉易损斑块形成过程中的作用机制[J].中风与神经疾病,2017,34(8):759-761.
[6]王少君,刘建,马海,等.强化他汀治疗急性脑梗死的疗效及安全性[J].中国老年学杂志,2016,36(10)：2376-2378.
[7]李欣慰.早期他汀类药物治疗联合静脉溶栓对急性脑梗死患者神经功能及细胞因子分泌的影响[J].海南医学院学报,2017,23(22):3058-3061.
[8]李强,华梅,李鸣,等.强化他汀治疗对脑梗死患者血清HMGB1 IL-17A和S-100A12水平的影响[J].中风与神经疾病,2016,33(2):109-112.

相似文献/References:

[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
　FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Medical Information,2018,31(05):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
　GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Medical Information,2018,31(05):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[3]王 伟,宫秀群,余 亮.阿替普酶治疗急性脑梗死患者临床转归的影响因素[J].医学信息,2022,35(11):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
　WANG Wei,GONG Xiu-qun,YU Liang.The Influencing Factors of Clinical Outcome in Patients with Acute Cerebral Infarction Treated with Alteplase[J].Medical Information,2022,35(05):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
[4]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
　CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Medical Information,2018,31(05):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[5]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
　LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Medical Information,2018,31(05):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[6]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
　CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Medical Information,2022,35(05):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[7]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
　WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Medical Information,2019,32(05):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[8]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
　ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Medical Information,2019,32(05):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
[9]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的 疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
　TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Medical Information,2019,32(05):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[10]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Medical Information,2019,32(05):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]

更新日期/Last Update: 2019-03-01